Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication (NCT06843512)
Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet
🩺 Plain-English Summary (8th-Grade Level)
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.
Who can join: Review the eligibility criteria below.
Location: Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University — State College, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
- GLP-1 Medication Initiation (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University — State College, Pennsylvania
📞 Contact the Study Coordinator
Phone: (425) 499-8049
Email: cmb8633@psu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Weight Loss
- VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) — Birmingham, Alabama
- Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) — Palo Alto, California
- Risk of Metabolic Adaptation After Weight Loss — Milwaukee, Wisconsin
- Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions — Baltimore, Maryland
- Choosing Healthy Activities and Lifestyle Management Through Portal Support — Memphis, Tennessee
- iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families — Kansas City, Kansas
Explore by condition: All Weight Loss clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.